Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
204.24
+1.69 (0.83%)
At close: Mar 3, 2026, 4:00 PM EST
204.99
+0.75 (0.37%)
Pre-market: Mar 4, 2026, 7:52 AM EST
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 68 employees as of December 31, 2024. The number of employees increased by 10 or 17.24% compared to the previous year.
Employees
68
Change (1Y)
10
Growth (1Y)
17.24%
Revenue / Employee
$3,942,456
Profits / Employee
$1,830,191
Market Cap
4.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | 155 | 40 | 34.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Corcept Therapeutics | 730 |
| ADMA Biologics | 685 |
| ACADIA Pharmaceuticals | 654 |
| Crinetics Pharmaceuticals | 594 |
| Amicus Therapeutics | 511 |
| TG Therapeutics | 374 |
| Structure Therapeutics | 218 |
| Centessa Pharmaceuticals | 114 |
LGND News
- 5 days ago - Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Ligand Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 20 days ago - Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 4 weeks ago - Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript - Seeking Alpha
- 3 months ago - Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance - GlobeNewsWire
- 3 months ago - Ligand Pharmaceuticals: Superb Q3/2025 With Second Guidance Raise Heralds Good Things To Come - Seeking Alpha
- 4 months ago - Ligand Pharmaceuticals Incorporated (LGND) Q3 2025 Earnings Call Transcript - Seeking Alpha